Abstract
ObjectiveTo assess the feasibility, safety, and predictive factors for the success of holmium laser enucleation of the prostate (HoLEP) with catheter removal and hospital discharge on the same day of the procedure. MethodsThis prospective study included 34 patients who underwent HoLEP using a 60-W holmium laser device and the Wolf Piranha morcellation system. Surgeries began at 10:30 am and the patients were expected to be discharged by 5 pm on the same day. The patients underwent a voiding trial to remove the urinary catheter before hospital discharge. Functional outcomes were assessed 90 days after the procedure. ResultsMean (range) age, prostate-specific antigen value, and prostate weight were as follows: 63.4 (50–80) years, 4.81 (0.19–14) ng/mL, and 89.3 (33–258) g, respectively. The mean (range) enucleation and morcellation times were 56.2 (29–91) min and 14.67 (3–45) min, respectively. Thirty-one patients (91.1%) were discharged on the same day of the procedure after urinary catheter removal. ConclusionThe performance of HoLEP is safe on an outpatient basis. Same-day catheter removal is feasible and does not affect hospital discharge.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
